Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30458003)

  • 1. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
    Meng C; Yin X; Liu J; Tang K; Tang H; Liao J
    PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis.
    Liang S; Chang L
    Biomark Med; 2018 Apr; 12(4):393-402. PubMed ID: 29575908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: a meta-analysis.
    Lee JH; Choi JW; Kim YS
    J Gastrointestin Liver Dis; 2011 Sep; 20(3):287-91. PubMed ID: 21961097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis.
    Hu H; Zhou C; Li B; Chen Y; Dai J; Mao Y; Huang T; Yu H; Chen M; Zhao J; Duan S
    Pathol Res Pract; 2018 Oct; 214(10):1572-1578. PubMed ID: 30082160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
    Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
    Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
    Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
    J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
    Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
    Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.
    Jiang X; Bai XY; Li B; Li Y; Xia K; Wang M; Li S; Wu H
    Dis Markers; 2019; 2019():5069614. PubMed ID: 31481982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
    Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
    Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of TIMP-1 level in serum and its immunohistochemical expression in colorectal cancer patients.
    Niewiarowska K; Pryczynicz A; Dymicka-Piekarska V; Gryko M; Cepowicz D; Famulski W; Kemona A; Guzińska-Ustymowicz K
    Pol J Pathol; 2014 Dec; 65(4):296-304. PubMed ID: 25693084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.
    Peng Z; Zhu W; Dai J; Ju F
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):77-85. PubMed ID: 29808805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
    Li C; He X; Zhang L; Li L; Zhao W
    BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
    Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
    Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.